This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,305.75 firm fixed-price delivery order is for the supply of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with an ultimate completion date of October 28, 2024.
The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.
Generated 1/24/25, 9:23 AM